Follow the MIRA PHARMACEUTICALS, INC. stock price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €31.1m. The latest transaction was reported on 3 October 2025 (Attribution). Among the most active insiders: Aminov Erez. The full history is free.
9
Insider Decl.
n/a
Thresholds
€2m
3 ops.
Buy Volume
€487,185
3 ops.
Sell Volume
32Σ signal
Buys €2m€487,185 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
157,170 shares@ US$7.0057.0% of flowCommon StockSEC:0000897069-23-001091:0
Canonical exit: 31 Oct 2023 (T+90)
9 of 9 declarations
Acerca de MIRA PHARMACEUTICALS, INC.
MIRA PHARMACEUTICALS, INC. es una empresa que cotiza en el mercado XNAS, especializada en el desarrollo de soluciones farmacéuticas innovadoras. Se centra en la investigación y comercialización de medicamentos para diversas áreas terapéuticas.